Since the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a growing body of evidence indicates that besides common COVID-19 symptoms, patients may develop various neurological manifestations affecting both the central and peripheral nervous systems as well as skeletal muscles. These manifestations can occur prior, during and even after the onset of COVID-19 general symptoms. In this Review, we discuss the possible neuroimmunological mechanisms underlying the nervous system and skeletal muscle involvement, and viral triggered neuroimmunological conditions associated with SARS-CoV-2, as well as therapeutic approaches that have been considered for these specific complications worldwide.
SARS-CoV-2 and nervous system: from pathogenesis to clinical manifestation / Kiandokht, Keyhanian; Pizzolato, Raffaella; Babak, Mohit; Vahid, Davoudi; Fatemeh, Hajighasemi; Mehdi, Ghasemi. - In: JOURNAL OF NEUROIMMUNOLOGY. - ISSN 0165-5728. - 350:(2021). [10.1016/j.jneuroim.2020.577436]
SARS-CoV-2 and nervous system: from pathogenesis to clinical manifestation
Raffaella Pizzolato;
2021
Abstract
Since the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a growing body of evidence indicates that besides common COVID-19 symptoms, patients may develop various neurological manifestations affecting both the central and peripheral nervous systems as well as skeletal muscles. These manifestations can occur prior, during and even after the onset of COVID-19 general symptoms. In this Review, we discuss the possible neuroimmunological mechanisms underlying the nervous system and skeletal muscle involvement, and viral triggered neuroimmunological conditions associated with SARS-CoV-2, as well as therapeutic approaches that have been considered for these specific complications worldwide.File | Dimensione | Formato | |
---|---|---|---|
Keyhanian_SARS-CoV-2_2020.pdf
solo gestori archivio
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
4.31 MB
Formato
Adobe PDF
|
4.31 MB | Adobe PDF | Contatta l'autore |
Keyhanian_SARS-CoV-2_2020.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
3.7 MB
Formato
Adobe PDF
|
3.7 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.